Document is current

Any future updates will be listed below

Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of ‘deep’ product reviews

Crossref DOI link: https://doi.org/10.1186/s12961-017-0259-8

Published Online: 2017-11-09

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark